A. Sender Liberman

机构：McGill University Health Centre, Mirati Therapeutics (United States), Celldex Therapeutics (United States), Fate Therapeutics (United States), McGill University · ORCID：0000-0002-4494-4834

发表论文 126 篇 · 总被引 7522 次 · h-index 35

代表论文

• Does a multimodal prehabilitation program improve sleep quality and duration in patients undergoing colorectal resection for cancer? Pilot randomized control trial (2023 · Journal of Behavioral Medicine · 被引 19)
• HTD1801 demonstrates promising potential for histologic improvements in metabolic dysfunction-associated steatohepatitis in both a preclinical and phase 2 study (2025 · Clinical and Molecular Hepatology · 被引 13)
• The impact of restorative proctectomy versus permanent colostomy on health-related quality of life after rectal cancer surgery using the patient-generated index (2023 · Surgery · 被引 11)
• Predictive Factors for Successful Same-Day Discharge After Minimally Invasive Colectomy and Stoma Reversal (2023 · Diseases of the Colon & Rectum · 被引 8)
• Co-Developed Logic Model for Surgical Prehabilitation in an Acute Care Setting: A Qualitative Study of Stakeholders’ Perspectives (2025 · Annals of Nutrition and Metabolism · 被引 7)
• A survey of preoperative surgical nutrition practices, opinions, and barriers across Canada (2024 · Applied Physiology Nutrition and Metabolism · 被引 7)